The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
A randomized, open-label, crossover study comparing the effects of oral versus transdermal estrogen therapy on serum androgens, thyroid hormones, and adrenal hormones in naturally menopausal women
Abstract
In Brief Objective: To compare the changes induced by oral versus transdermal estrogen therapy on the total and free serum concentrations of testosterone (T), thyroxine (T4), and cortisol (C) and the concentrations of their serum binding globulins sex hormone-binding globulin, thyroxine-binding globulin, and cortisol-binding globulin in naturally menopausal women. Design: Randomized, open-label, crossover. Interventions included a 6-week withdrawal from previous hormone therapy (baseline), followed in randomized order by 12 weeks of oral conjugated equine estrogens (CEE) (0.625 mg/d) and 12 weeks of transdermal estradiol (TD E2) (0.05 mg/d), with oral micronized progesterone (100 mg/d) given continuously during both transdermal estrogen therapy regimens. Results: Twenty-seven women were enrolled in the study, and 25 completed both treatment periods. The mean(SD) percentage changes from baseline of sex hormone-binding globulin, total T, and free T with oral CEE were +132.1% (74.5%), +16.4% (43.8%), and −32.7% (25.9%), respectively, versus +12.0% (25.1%), +1.2% (43.7%), and +1.0% (45.0%) with TD E2. The mean (SD) percentage changes of thyroxine-binding globulin, total T4, and free T4 with oral CEE were +39.9% (20.1%), +28.4% (29.2%), and −10.4% (22.3%), respectively, versus +0.4% (11.1%), −0.7% (16.5%), and +0.2% (26.6%) with TD E2. The mean (SD) percentage changes of cortisol-binding globulin, total C, and free C with oral CEE were +18.0% (19.5%), +29.2% (46.3%), and +50.4% (126.5%), respectively, versus −2.2% (11.3%), −6.7% (30.8%), and +1.8% (77.1%) with TD E2. Concentrations of all hormones and binding globulins were significantly different (P ≤ 0.003) during administration of oral versus transdermal estrogen therapy, except for free T4 and free C. Conclusions: Compared with oral CEE, TD E2 exerts minimal effects on the total and free concentrations of T, T4, and C and their binding proteins. This study compared the effects of oral conjugated equine estrogens (0.625 mg/day) versus transdermal estradiol (0.05 mg/day) on the total and free concentrations of testosterone, thyroxine, and cortisol and their serum binding proteins sex hormone-binding globulin, thyroxine-binding globulin, and cortisol-binding globulin in naturally menopausal women. By avoiding the hepatic first-pass effect, transdermal estradiol may be preferable to oral conjugated equine estrogens in maintaining free testosterone levels, minimizing potential interaction with thyroid replacement therapy and having little effect on total or free cortisol levels.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Some studies also report increased fT3 levels with no significant effects on TSH levels.”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [191]
In the citing paper
“In patients with GHD, 36-47% of euthyroid patients and 16-18% of treated CH patients developed low fT4 levels within 3-6 month of starting GH therapy (191,193).”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [191]
In the citing paper
“Administering GH to GHD adults causes variable changes in thyroid hormone levels-the most consistent effect being decreased fT4 levels (81,191,192).”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [191]
In the citing paper
“Most patients, who were at increased risk of developing CH while receiving GH and who had previously undergone surgery and/or radiation therapy for pituitary tumors, had lower basal T4 levels and were more likely to have other multiple hormone deficiencies.”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [191]
In the citing paper
“These effects can decrease fT4 levels into the hypothyroid range, suggesting that untreated GHD can mask CH by artificially maintaining fT4 levels in the reference range.”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [191]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
An analysis of variance test for normality (complete samples)
SHAPIRO, S. S., & WILK, M. B. (1965) · Biometrika · doi:10.1093/biomet/52.3-4.591 · Cited by 23,480
A concordance correlation coefficient to evaluate reproducibility.
Lin, L. I.-K. (1989) · Biometrics · doi:10.2307/2532051 · Cited by 8,785
The Colorado Thyroid Disease Prevalence Study
Canaris, G. J., Manowitz, N. R., Mayor, G., & Ridgway, E. C. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.4.526 · Cited by 2,824
The Free Hormone Hypothesis: A Physiologically Based Mathematical Model*
MENDEL, C. M. (1989) · Endocrine Reviews · doi:10.1210/edrv-10-3-232 · Cited by 961 · cited 1×
“The elevations of SHBG, TBG, and CBG associated with oral ET would be expected to reduce the MCRs of the respective hormones to an extent that would depend on the globulin concentrations and the kinetic processes involved in the clearance of each hormone.(10,42) In a cross-sectional study of postmenopausal women, the…”
BackgroundTransdermal testosterone treatment in women with impaired sexual function after oophorectomy.
Shifren, J. L., Braunstein, G. D., Simon, J. A., Casson, P. R., Buster, J. E., Redmond, G. P., Burki, R. E., Ginsburg, E. S., Rosen, R. C., Leiblum, S. R., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009073431002 · Cited by 954 · cited 6×
“Normal range for premenopausal women.(11) Normal range for postmenopausal women.”
BackgroundInfluentialSelf-citationThe Two-Period Change-Over Design and Its Use in Clinical Trials
Grizzle, J. E. (1965) · Biometrics · doi:10.2307/2528104 · Cited by 784
Biologic Effects of Transdermal Estradiol
Chetkowski, R. J., Meldrum, D. R., Steingold, K. A., Randle, D., Lu, J. K., Eggena, P., Hershman, J. M., Alkjaersig, N. K., Fletcher, A. P., & Judd, H. L. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606193142505 · Cited by 468
Biologic effects of transdermal estradiol
Chetkowski, R., Meldrum, D., & Steingold, K. (1987) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(87)90325-0 · Cited by 467 · cited 1×
“a result of the hepatic first-pass metabolism of estrogens after oral administration.(5) A well-known example of this is the dose-dependent increases in the serum concentrations of sex hormoneYbinding globulin (SHBG), thyroxine-binding globulin (TBG), and cortisol-binding globulin (CBG), glycoproteins synthesized and…”
BackgroundBraunstein, G. D., Sundwall, D. A., Katz, M., Shifren, J. L., Buster, J. E., Simon, J. A., Bachman, G., Aguirre, O. A., Lucas, J. D., Rodenberg, C., et al. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.14.1582 · Cited by 458
Self-citationCommonly Used Types of Postmenopausal Estrogen for Treatment of Hot Flashes: Scientific Review
Nelson, H. D. (2004) · JAMA · doi:10.1001/jama.291.13.1610 · Cited by 296 · cited 1×
“05 mg/d) used in this study in conjunction with daily oral MP (100 mg/d) are typical of the ET/HT treatments commonly used in the United States and are generally viewed as similarly effective in the treatment of menopausal symptoms.(1,2,19) Despite the differences in free E2 and free E1 levels attained with each regim…”
Method
Cited by
The 2017 hormone therapy position statement of The North American Menopause Society
(2017) · Menopause · doi:10.1097/gme.0000000000000921 · Cited by 1,001
The 2022 hormone therapy position statement of The North American Menopause Society
(2022) · Menopause · doi:10.1097/gme.0000000000002028 · Cited by 977
“FDA guidance for treatment of genitourinary symptoms related to menopause in the absence of indications for systemic ET suggests the use of low-dose topical vaginal ET.”
InfluentialSelf-citationHormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline
Fleseriu, M., Hashim, I. A., Karavitaki, N., Melmed, S., Murad, M. H., Salvatori, R., & Samuels, M. H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2118 · Cited by 945
Woods, N. F., Smith-DiJulio, K., Percival, D. B., Tao, E. Y., Mariella, A., & Mitchell, E. S. (2008) · Menopause · doi:10.1097/gme.0b013e3181450fc2 · Cited by 345
Sex hormone binding globulin and insulin resistance
Wallace, I. R., McKinley, M. C., Bell, P. M., & Hunter, S. J. (2013) · Clinical Endocrinology · doi:10.1111/cen.12086 · Cited by 268
Metadata
- Authors
- Shifren, J. L., Desindes, S., McIlwain, M., Doros, G., & Mazer, N. A.
- Affiliations
- Harvard University (US)
- Université de Sherbrooke (CA)
- Boston University (US)
- Corresponding author
- Mazer, Norman A.
- Venue
- Menopause
- Published
- 2007-11
- Volume
- 14
- Issue
- 6
- Pages
- 985-994
- ISSN
- 1072-3714 (ISSN-L)
- OpenAlex
- W2004838536
- Cited by
- 89
- References
- 50
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 3 · 2023: 4 · 2022: 6 · 2021: 6 · 2019: 4 · 2018: 5 · 2017: 5 · 2016: 2 · 2015: 5 · 2014: 3 · 2013: 2 · 2012: 4
- FWCI
- 7.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Menopause The Journal of The North American Menopause Society (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- transdermal estradiol, menopause, sex hormone-binding globulin, thyroxine-binding globulin, corticosteroid-binding globulin, testosterone, thyroxine, cortisol, adrenal function, thyroid function, micronized progesterone, hormone withdrawal, natural menopause
- MeSH terms
- Administration, Cutaneous, Administration, Oral, Adult, Aged, Carrier Proteins, Estrogens, Conjugated (USP), Female, Humans, Menopause, Middle Aged, Progesterone, Testosterone, Thyroxine, Estrogen Replacement Therapy, Treatment Outcome, Cross-Over Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A randomized, open-label, crossover study comparing the effects of oral versus transdermal estrogen therapy on serum androgens, thyroid hormones, and adrenal hormones in naturally menopausal women. https://app.cochat.ai/papers/10.1097/gme.0b013e31803867a
- The paper
- Shifren, J. L., Desindes, S., McIlwain, M., Doros, G., & Mazer, N. A. (2007). A randomized, open-label, crossover study comparing the effects of oral versus transdermal estrogen therapy on serum androgens, thyroid hormones, and adrenal hormones in naturally menopausal women. Menopause. https://doi.org/10.1097/gme.0b013e31803867a
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.